United Kingdom

Showing 21-30 of 35 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Can dysregulated immunity to bacterial lipopolysaccharide aid in identifying those at risk of developing Type 1 diabetes?	University of Birmingham	James Pearson	Cures	01-April-2026 to 31-March-2029	$667,691.00
Progressing 4 antibody multiplex Lateral flow assay for Diabetes (Diabetes 4ward)	University of Birmingham	Alex Richter	Cures	01-August-2024 to 31-July-2026	$705,592.01
Macrophages To Promote The Long-Term Function Of Islets Following Transplantation For Type 1 Diabetes.	The University of Edinburgh	Shareen Forbes	Cures	01-March-2024 to 28-February-2027	$748,578.27
Unraveling the Mechanisms of HLA-DQ8 Graft Acceptance: Insights from the Largest Single Cohort of Islet Transplant Recipients in the Edmonton Program	The University of Edinburgh	Shareen Forbes	Cures	01-October-2025 to 30-September-2027	$749,938.79
Targeting alpha/beta hydrolase domain containing 11 (ABHD11) as a therapeutic target in type 1 diabetes	Swansea University	Nicholas Jones	Cures	01-April-2026 to 31-March-2029	$621,914.00
My T1D Care Tool: Co-Creating a digital psychosocial measure for young people living with Type 1 Diabetes as part of routine healthcare management	Queen’s University Belfast	Emma Berry	Improving Lives	01-July-2023 to 30-June-2026	$105,597.77
Development of a point of care immunosensor for c-peptide assessment	Lancaster University	Samet Sahin	Cures	01-December-2024 to 30-November-2027	$558,291.85
Investigating and Optimising the translational potential of NAMPT inhibition in type 1 diabetes	King’s College London	Paul Caton	Cures	01-November-2025 to 31-October-2028	$859,147.00
Developing The Translational Potential Of The NPY Y4 Receptor For Treating Type 1 Diabetes	King’s College London	Gavin Bewick	Cures	01-June-2022 to 30-November-2026	$960,119.92
Targeting the islet resident immune population to prevent T1D	King’s College London	Gavin Bewick	Cures	01-October-2024 to 30-September-2027	$899,758.00